Light-Activated Hydrogen Nanoparticles Boost Bladder Cancer Treatment
- Authors
- Rui Sun, Xiaocen Liu, Guangzhi Li, Hui Wang, Yongxiang Luo, Guixiao Huang, Xisheng Wang, Guohua Zeng, Zhuang Liu, Song Wu
- Journal
- ACS Nano
- Year
- 2020
- DOI
- 10.1021/acsnano.0c01300
- Study Type
- Cell Culture
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Bladder Cancer
- Body System
- Urinary System
TL;DR
Scientists have created a light-activated nanoparticle that generates hydrogen gas to enhance the effectiveness of chemotherapy for bladder cancer treatment.
Key Finding
Hydrogen gas generated by laser-activated nanoparticles enhanced chemotherapy effectiveness against bladder cancer cells by reducing the cancer cells' ability to expel the drug and disrupting their energy production.
Summary
Researchers developed tiny particles that combine a chemotherapy drug, a catalyst (a substance that speeds up chemical reactions), and a special material. When exposed to specific laser light, these particles generate hydrogen gas directly inside bladder cancer cells. In laboratory tests, this combination of hydrogen gas and chemotherapy was more effective at killing cancer cells than chemotherapy alone, partly because the hydrogen gas interfered with how cancer cells pump out the drug.
Practical Takeaway
This is early laboratory research in cells, not human studies, so it does not yet demonstrate safety or effectiveness in people. The approach requires specialized laser equipment and direct delivery into the bladder, making it very different from drinking hydrogen water. While the results suggest hydrogen gas may have a role in cancer treatment strategies, much more research is needed before any clinical applications.
Abstract
Hydrogen gas can mitigate oxidative stress in many diseases that is regarded to be safe and free of side effect. Inspired by a metalloenzyme in a variety of microorganisms, here we propose a photo-activated H2 nanogenerator that comprises a fluorinated chitosan (FCS), a chemotherapeutic drug (Gemcitabine, GEM), and a catalyst of H2 production ([FeFe]TPP) that can form self-assembled [FeFe]TPP/GEM/FCS nanoparticles (NPs). The [FeFe]TPP/GEM/FCS NPs exhibit excellent transmucosal and tumor cell penetration capacities after intravesical instillation into the bladder, and can efficiently produce H2 gas in situ upon a 660 nm laser irradiation, which significantly enhances the efficacy of hydrogen-chemotherapy of cancer in vitro and in vivo. Moreover, we discover that H2 gas in hydrogen-chemotherapy can inhibit mitochondrial function, hinder ATP synthesis, and cause the reduction of P-gp efflux pump function, which finally attenuate P-gp protein drug transport capacity in cancer cells. This photo-activated H2 evolution in situ to improve the therapeutic efficacy of chemotherapy of bladder cancer may present an effective hydrogen-chemotherapy strategy for cancer treatment.